Renal Cancer Clinical Quality Performance Indicators: Engagement Document

This document is being circulated for comment and feedback in order to ensure wide

engagement with professional groups, health service staff, voluntary organisations, patients affected by renal cancer and the wider public.

2. Quality Performance Indicator Development Process

The QPI development process was designed to ensure that indicators are developed in an open, transparent and timely way. The development process can be found in appendix 1.

The Renal Cancer QPI Development Group was convened in May 2010, chaired by Dr Robert Masterton (Chair of the National Cancer Quality Steering Group). Membership of this group included clinical representatives drawn from the three regional cancer networks, Healthcare Improvement Scotland, Information Services Division ( ISD) and patient/carer representatives. Membership of the development group can be found in appendix 2.


Back to top